Standard Family Office LLC Biomarin Pharmaceutical Inc Transaction History

Standard Family Office LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $714 - $868	10 New	10 $1,000
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $1,337 - $1,668	-18 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $1,290 - $1,646	18 New	18 $2,000
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $1,345 - $1,632	-18 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1,306 - $1,623	18 New	18 $2,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Standard Family Office LLC with notifications on news.